The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma
BackgroundDespite the significant progress in the treatment of multiple myeloma (MM), the disease remains untreatable and its cure is still an unmet clinical need. Neoplastic transformation in MM is initiated in the germinal centers (GCs) of secondary lymphoid tissue (SLT) where B cells experience e...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-12-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1009993/full |
| _version_ | 1797980095342706688 |
|---|---|
| author | Nesreen Amer Ramadan Aly Nesreen Amer Ramadan Aly Samia Rizk Azza Aboul Enein Nermeen El Desoukey Hamdy Zawam Manzoor Ahmed Mohey Eldin El Shikh Costantino Pitzalis |
| author_facet | Nesreen Amer Ramadan Aly Nesreen Amer Ramadan Aly Samia Rizk Azza Aboul Enein Nermeen El Desoukey Hamdy Zawam Manzoor Ahmed Mohey Eldin El Shikh Costantino Pitzalis |
| author_sort | Nesreen Amer Ramadan Aly |
| collection | DOAJ |
| description | BackgroundDespite the significant progress in the treatment of multiple myeloma (MM), the disease remains untreatable and its cure is still an unmet clinical need. Neoplastic transformation in MM is initiated in the germinal centers (GCs) of secondary lymphoid tissue (SLT) where B cells experience extensive somatic hypermutation induced by follicular dendritic cells (FDCs) and T-cell signals.ObjectiveWe reason that secreted protein acidic and rich in cysteine (SPARC), a common stromal motif expressed by FDCs at the origin (SLTs) and the destination (BM) of MM, plays a role in the pathogenesis of MM, and, here, we sought to investigate this role.MethodsThere were 107 BM biopsies from 57 MM patients (taken at different time points) together with 13 control specimens assessed for SPARC gene and protein expression and compared with tonsillar tissues. In addition, regulation of myeloma-promoting genes by SPARC-secreting FDCs was assessed in in vitro GC reactions (GCRs).ResultsSPARC gene expression was confirmed in both human primary (BM) and secondary (tonsils) lymphoid tissues, and the expression was significantly higher in the BM. Sparc was detectable in the BM and tonsillar lysates, co-localized with the FDC markers in both tissues, and stimulation of FDCs in vitro induced significantly higher levels of SPARC expression than unstimulated controls. In addition, SPARC inversely correlated with BM PC infiltration, ISS staging, and ECOG performance of the MM patients, and in vitro addition of FDCs to lymphocytes inhibited the expression of several oncogenes associated with malignant transformation of PCs.ConclusionFDC-SPARC inhibits several myelomagenic gene expression and inversely correlates with PC infiltration and MM progression. Therapeutic induction of SPARC expression through combinations of the current MM drugs, repositioning of non-MM drugs, or novel drug discovery could pave the way to better control MM in clinically severe and drug-resistant patients. |
| first_indexed | 2024-04-11T05:48:55Z |
| format | Article |
| id | doaj.art-7b0ff02fca9b441085f9bb3e5e5e32d3 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-04-11T05:48:55Z |
| publishDate | 2022-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-7b0ff02fca9b441085f9bb3e5e5e32d32022-12-22T04:42:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10099931009993The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myelomaNesreen Amer Ramadan Aly0Nesreen Amer Ramadan Aly1Samia Rizk2Azza Aboul Enein3Nermeen El Desoukey4Hamdy Zawam5Manzoor Ahmed6Mohey Eldin El Shikh7Costantino Pitzalis8Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, EgyptCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomClinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, EgyptClinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, EgyptClinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, EgyptClinical Oncology and Nuclear Radiation Department, Faculty of Medicine, Cairo University, Cairo, EgyptCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomBackgroundDespite the significant progress in the treatment of multiple myeloma (MM), the disease remains untreatable and its cure is still an unmet clinical need. Neoplastic transformation in MM is initiated in the germinal centers (GCs) of secondary lymphoid tissue (SLT) where B cells experience extensive somatic hypermutation induced by follicular dendritic cells (FDCs) and T-cell signals.ObjectiveWe reason that secreted protein acidic and rich in cysteine (SPARC), a common stromal motif expressed by FDCs at the origin (SLTs) and the destination (BM) of MM, plays a role in the pathogenesis of MM, and, here, we sought to investigate this role.MethodsThere were 107 BM biopsies from 57 MM patients (taken at different time points) together with 13 control specimens assessed for SPARC gene and protein expression and compared with tonsillar tissues. In addition, regulation of myeloma-promoting genes by SPARC-secreting FDCs was assessed in in vitro GC reactions (GCRs).ResultsSPARC gene expression was confirmed in both human primary (BM) and secondary (tonsils) lymphoid tissues, and the expression was significantly higher in the BM. Sparc was detectable in the BM and tonsillar lysates, co-localized with the FDC markers in both tissues, and stimulation of FDCs in vitro induced significantly higher levels of SPARC expression than unstimulated controls. In addition, SPARC inversely correlated with BM PC infiltration, ISS staging, and ECOG performance of the MM patients, and in vitro addition of FDCs to lymphocytes inhibited the expression of several oncogenes associated with malignant transformation of PCs.ConclusionFDC-SPARC inhibits several myelomagenic gene expression and inversely correlates with PC infiltration and MM progression. Therapeutic induction of SPARC expression through combinations of the current MM drugs, repositioning of non-MM drugs, or novel drug discovery could pave the way to better control MM in clinically severe and drug-resistant patients.https://www.frontiersin.org/articles/10.3389/fonc.2022.1009993/fullmultiple myelomaSPARCbone marrowfollicular dendritic cellsgerminal center reactionstumor microenvironments |
| spellingShingle | Nesreen Amer Ramadan Aly Nesreen Amer Ramadan Aly Samia Rizk Azza Aboul Enein Nermeen El Desoukey Hamdy Zawam Manzoor Ahmed Mohey Eldin El Shikh Costantino Pitzalis The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma Frontiers in Oncology multiple myeloma SPARC bone marrow follicular dendritic cells germinal center reactions tumor microenvironments |
| title | The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma |
| title_full | The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma |
| title_fullStr | The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma |
| title_full_unstemmed | The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma |
| title_short | The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma |
| title_sort | role of lymphoid tissue sparc in the pathogenesis and response to treatment of multiple myeloma |
| topic | multiple myeloma SPARC bone marrow follicular dendritic cells germinal center reactions tumor microenvironments |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.1009993/full |
| work_keys_str_mv | AT nesreenamerramadanaly theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT nesreenamerramadanaly theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT samiarizk theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT azzaaboulenein theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT nermeeneldesoukey theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT hamdyzawam theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT manzoorahmed theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT moheyeldinelshikh theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT costantinopitzalis theroleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT nesreenamerramadanaly roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT nesreenamerramadanaly roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT samiarizk roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT azzaaboulenein roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT nermeeneldesoukey roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT hamdyzawam roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT manzoorahmed roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT moheyeldinelshikh roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma AT costantinopitzalis roleoflymphoidtissuesparcinthepathogenesisandresponsetotreatmentofmultiplemyeloma |